共 247 条
[1]
Chi A(2010)Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications Radiother Oncol 94 1-11
[2]
Liao Z(2011)Stereotactic body radiotherapy versus surgery for medically operable stage I non-small-cell lung cancer: a Markov model-based decision analysis Int J Radiat Oncol Biol Phys 81 964-973
[3]
Nguyen NP(2012)Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly Int J Radiat Oncol Biol Phys 84 1060-1070
[4]
Xu J(2015)Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study Int J Radiat Oncol Biol Phys 91 337-343
[5]
Stea B(2011)Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410 J Natl Cancer Inst 103 1452-1460
[6]
Komaki R(2015)Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Lancet Oncol 16 187-199
[7]
Louie AV(2013)Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer J Clin Oncol 31 4343-4348
[8]
Rodrigues G(2015)Precision hypofractionated radiation therapy in poor performing patients with non-small cell lung cancer: phase I dose escalation trial Int J Radiat Oncol Biol Phys 93 72-81
[9]
Hannouf M(2013)Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centres Radiother Oncol 109 8-12
[10]
Zaric GS(2009)Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs Radiother Oncol 93 122-124